Litcius/Paper detail

Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer

Julia Paik

2021Targeted Oncology32 citationsDOI

Topics & Concepts

OlaparibMedicineBevacizumabOvarian cancerOncologyInternal medicinePARP inhibitorTolerabilityBRCA mutationFallopian tube cancerMaintenance therapyChemotherapyCancerAdverse effectPolymeraseBiochemistryChemistryGenePoly ADP ribose polymerasePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer
Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer | Litcius